Go Pro
→ ALERT: Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel Free AIMDW Stock Alerts

Ainos (AIMDW) Competitors

Ainos logo
$0.11 +0.02 (+18.89%)
As of 07/17/2026 03:53 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

AIMDW vs. ALVOW, ARAV, ACABW, BFRIW, and CELUW

Should you buy Ainos stock or one of its competitors? MarketBeat compares Ainos with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Ainos include Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

How does Ainos compare to Alvotech?

Ainos (NASDAQ:AIMDW) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, earnings, institutional ownership, risk and profitability.

In the previous week, Ainos' average media sentiment score of 0.00 equaled Alvotech'saverage media sentiment score.

Company Overall Sentiment
Ainos Neutral
Alvotech Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ainos$18.11KN/AN/AN/AN/A
Alvotech$559.42MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
AinosN/A N/A N/A
Alvotech N/A N/A N/A

Summary

Alvotech beats Ainos on 1 of the 1 factors compared between the two stocks.

How does Ainos compare to Aravive?

Ainos (NASDAQ:AIMDW) and Aravive (NASDAQ:ARAV) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, valuation, risk, media sentiment and analyst recommendations.

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
AinosN/A N/A N/A
Aravive N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ainos$18.11KN/AN/AN/AN/A
AraviveN/AN/AN/A-$0.90N/A

In the previous week, Ainos' average media sentiment score of 0.00 equaled Aravive'saverage media sentiment score.

Company Overall Sentiment
Ainos Neutral
Aravive Neutral

Summary

Aravive beats Ainos on 2 of the 3 factors compared between the two stocks.

How does Ainos compare to Atlantic Coastal Acquisition Corp. II?

Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and Ainos (NASDAQ:AIMDW) are both pharmaceutical products companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, media sentiment, risk and valuation.

In the previous week, Atlantic Coastal Acquisition Corp. II's average media sentiment score of 0.00 equaled Ainos'average media sentiment score.

Company Overall Sentiment
Atlantic Coastal Acquisition Corp. II Neutral
Ainos Neutral

Company Net Margins Return on Equity Return on Assets
Atlantic Coastal Acquisition Corp. IIN/A N/A N/A
Ainos N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A
Ainos$18.11KN/AN/AN/AN/A

Summary

Ainos beats Atlantic Coastal Acquisition Corp. II on 1 of the 1 factors compared between the two stocks.

How does Ainos compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, media sentiment, earnings, analyst recommendations, profitability and risk.

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
Ainos N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$43.20MN/AN/AN/AN/A
Ainos$18.11KN/AN/AN/AN/A

In the previous week, Biofrontera's average media sentiment score of 0.00 equaled Ainos'average media sentiment score.

Company Overall Sentiment
Biofrontera Neutral
Ainos Neutral

Summary

Biofrontera beats Ainos on 1 of the 1 factors compared between the two stocks.

How does Ainos compare to Celularity?

Ainos (NASDAQ:AIMDW) and Celularity (NASDAQ:CELUW) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, media sentiment, profitability, dividends, analyst recommendations and valuation.

Company Net Margins Return on Equity Return on Assets
AinosN/A N/A N/A
Celularity N/A N/A N/A

In the previous week, Celularity had 1 more articles in the media than Ainos. MarketBeat recorded 1 mentions for Celularity and 0 mentions for Ainos. Ainos' average media sentiment score of 0.00 equaled Celularity'saverage media sentiment score.

Company Overall Sentiment
Ainos Neutral
Celularity Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ainos$18.11KN/AN/AN/AN/A
Celularity$26.55MN/AN/AN/AN/A

Summary

Celularity beats Ainos on 2 of the 2 factors compared between the two stocks.

Get Ainos News Delivered to You Automatically

Sign up to receive the latest news and ratings for AIMDW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AIMDW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AIMDW vs. The Competition

Export
MetricAinosMedical Devices IndustryMedical SectorNASDAQ Exchange
Market CapN/A$2.15B$6.86B$12.28B
Dividend YieldN/A2.64%2.67%9.34%
P/E RatioN/A15.0427.2523.92
Price / SalesN/A128.82517.7888.83
Price / CashN/A15.9952.9960.41
Price / BookN/A4.5510.696.18
Net IncomeN/A$144.75M$3.59B$332.29M
7 Day Performance-11.38%-0.58%-2.20%-2.05%
1 Month PerformanceN/A1.25%1.63%-2.18%
1 Year Performance-28.61%-4.48%25.64%17.67%

Ainos Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AIMDW
Ainos
N/A$0.13
+42.8%		N/A-28.6%$0.00$18.11KN/A40
ALVOW
Alvotech
N/A$0.13
flat		N/AN/A$0.00$559.42MN/A4
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat		N/AN/A$0.00N/AN/A15
BFRIW
Biofrontera
N/A$0.03
flat		N/A-79.8%$0.00$43.20MN/A70

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:AIMDW) was last updated on 7/19/2026 by MarketBeat.com Staff.
From Our Partners
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Elon’s new "tollbooth"
The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...
Weiss Ratings | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel
Oil is settling in yuan now - here's what that means for gold
Saudi Arabia has terminated its 1974 petrodollar agreement with the United States - the deal that forced every...
Golden Portfolio | Sponsoredtc pixel